Elan Pharmaceuticals
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Elan Pharmaceuticals sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Elan Pharmaceuticals: 5 sponsored US clinical trials, none currently recruiting.
Elan Pharmaceuticals sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. 3 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Muscle Spasticity, with 1 trials.
Upper-quartile sponsor footprint
Elan Pharmaceuticals sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
5 total, page 1 of 1
A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis
NCT01144351
Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain
NCT00076544
Prialt (Ziconotide) In Severe Chronic Pain
NCT00047749
Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.
NCT00047580
A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache
NCT00055484
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 3 | 3 |
Therapeutic Areas
How the Elan Pharmaceuticals archive is shaped
5 indexed studies, none listed as recruiting (0% open); 4 completed (80%).
Phase mix: 3 late (III/IV) vs 2 early (I/II) (balanced across stages).
Top condition: Muscle Spasticity (1 trial), 3 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Elan Pharmaceuticals: archived-pipeline peers nationwide
Peers matched on 5 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Elan Pharmaceuticals sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 archived trials
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Elan Pharmaceuticals page
5 registered trials is a research-attention snapshot, not an endorsement of Elan Pharmaceuticals or any single study.
- None of Elan Pharmaceuticals's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Muscle Spasticity is the condition Elan Pharmaceuticals studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Muscle Spasticity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Elan Pharmaceuticals pipeline card: 5 registered trials from official public datasets.Report a data error.